Investigating the Inotropic Potential of Apelin

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The apelin-APJ system is a recently discover hormone system that has several important actions in the cardiovascular system. Apelin causes the heart pump with more force and also causes blood vessels to relax. Studies to date show that people with reduced pumping function of the heart have lower levels of apelin in the bloodstream compared to people with normal heart function. We have previously given apelin to healthy volunteers and people with reduced pumping function and this increases the heart's contraction. However, this has only been assessed over a short time period, around fifteen minutes, and we now want to know if this effect is seen over a longer period.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Edinburgh

Criteria

Inclusion Criteria:

Healthy volunteers:

>18yrs

Heart failure patients;

• New York Heart Failure class II-IV

• Ejection fractional <35% or fractional shortening <20% within previous 6months.

Exclusion Criteria:

All subjects,

• Females of child bearing age not on adequate contraception

• Lack of informed consent

• Age <18yrs

• Current involvement in any other research study

• Systolic BP >190 or <100

• Malignant arrhythmias

• Renal or hepatic failure

• Haemodynamically significant aortic stenosis

• Severe or significant co-morbidity

• Pacemakers

Healthy volunteers

• Any regular medication

• Previous history of any cardiovascular disease